Stock AVBP ARRIVENT BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages ArriVent BioPharma, Inc.

Equities

AVBP

US04272N1028

Market Closed - Nasdaq
Other stock markets
 20:59:52 30/05/2024 BST 		5-day change 1st Jan Change
19.66 USD +4.69% Intraday chart for ArriVent BioPharma, Inc. +3.02% 0.00%
05-16 ArriVent BioPharma, Inc. Appoints John Hohneker as Board of Directors CI
05-08 ArriVent BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ArriVent BioPharma, Inc. Appoints John Hohneker as Board of Directors
ArriVent BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
ArriVent BioPharma, Inc. Appoints Kristine Peterson to Its Board of Directors
Arrivent Biopharma Insider Bought Shares Worth $7,999,992, According to a Recent SEC Filing
Arrivent Biopharma Insider Bought Shares Worth $7,999,992, According to a Recent SEC Filing
ArriVent BioPharma, Inc. has completed an IPO in the amount of $174.999996 million.
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AVBP Stock
  4. News ArriVent BioPharma, Inc.
  5. Other languages